Wednesday, March 30, 2011

Do polymorphic variants of chromosomes affect the outcome of in vitro fertilization and embryo transfer treatment?

Your ADS Text

Skip Navigation

Y. Hong1, Y.-W. Zhou1, J. Tao2, S.-X. Wang2 and X.-M. Zhao1,*
1Department of Reproductive Medicine, Renji Hospital of Shanghai Jiaotong University, Shanghai 200001, China
2Pediatric Medicine Research Institute, Xinhua Hospital of Shanghai Jiaotong University, Shanghai 200092, China *Correspondence address. E-mail: zhao_xiao_ming{at}hotmail.comReceived November 15, 2009. Revision received October 7, 2010. Accepted November 8, 2010. BACKGROUND The aim of this study was to investigate the effect of chromosomal polymorphic variations on the outcome of IVF and embryo transfer (IVF–embryo transfer) treatment for infertile couples.

METHODS During the period from October 2006 to December 2009, 1978 infertile couples who had received their first IVF–embryo transfer treatment cycle in our hospital were selected for this retrospective study, and the frequency of chromosomal polymorphic variations was calculated. From these, 1671 couples were selected and divided into three groups: 1402 couples with normal chromosomes (Group 1/control group), 82 couples with chromosomal polymorphic variations in only females (Group 2) and 187 couples with chromosomal polymorphic variations in only males (Group 3). The clinical pregnancy rates (CPR), early miscarriage rates and ongoing pregnancy rates after IVF–embryo transfer treatment were compared.

RESULTS There were no statistically significant differences among the three groups in implantation rates (29.37% in the control group, 29.70% in Group 2 and 31.41% in Group 3, P > 0.05) and CPR (45.86, 46.34 and 51.87%, respectively, P > 0.05). Although there was a trend toward higher first trimester pregnancy loss rates in Group 3 (male chromosomal polymorphic variations), but not in Group 2, compared with normal karyotype couples (10.31 versus 6.84%), the difference did not reach significance (P > 0.05).

CONCLUSIONS Chromosomal polymorphic variations appear to have no adverse effects on the outcome of IVF–embryo transfer treatment.

© The Author 2011. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

This ArticleHum. Reprod. (2011) 26 (4): 933-940. doi: 10.1093/humrep/deq333 First published online: January 25, 2011

Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.



View the original article here



Peliculas Online

No comments:

Post a Comment